Skip to main content
Clinical Trials/NCT01336595
NCT01336595CompletedPhase 4

Comparison of Total Knee Arthroplasties With Oxidized Zirconium and Cobalt Chromium Femoral Components in the Same Patients: A Prospective, Double Blinded, and Randomized Controlled Study

Ewha Womans University1 site in 1 country331 target enrollmentStarted: January 1, 2003Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
331
Locations
1
Primary Endpoint
Improvement in Knee Society Knee Score

Study Overview

Brief Summary

The purpose of this study is to determine if there are any clinical or radiographic differences in cemented total knee arthroplasty with an oxidized zirconium and a cobalt-chromium femoral knee component.

Detailed Description

Although it has been claimed that total knee arthroplasties with an oxidized zirconium femoral knee component had beneficial wear properties in vitro, there are conflicting clinical results. The purpose of the present study was to compare the clinical, subjective, and radiographic results as well as the weight, size and shape of polyethylene wear particles in the patients with an oxidized zirconium and a cobalt-chromium femoral knee component.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
30 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •End-stage osteoarthritis of the knee joint requiring total knee arthroplasty with bilateral disease

Exclusion Criteria

  • •Inflammatory disease
  • •patient with other Lower extremity disease which may affect functional outcome
  • •Neurologic disease effecting patients lower extremity
  • •Revision surgery
  • •Patient not medically cleared for bilateral surgery

Arms & Interventions

Zirconium Femoral Component

Experimental

Oxidized zirconium femoral component of Genesis II TKR system is used.

Intervention: Zirconium (Zirconium Genesis II) (Device)

Cobalt Chrome

Active Comparator

Cobalt-Chromium Femoral component of Genesis II system is used.

Intervention: Cobalt-Chrome (Cobalt Chrome Genesis II) (Device)

Outcomes

Primary Outcomes

Improvement in Knee Society Knee Score

Time Frame: Initial(one day before surgery), and at 3 months, 1 year, then annually after surgery

change in knee score will be compared with initial score, until mean follow up of 20 years.

Secondary Outcomes

  • Improvement in the range of motion(Initial(one day before surgery), and at 3 months, 1 year, then annually after surgery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Young Hoo Kim

Professor and Director

Ewha Womans University

Study Sites (1)

Loading locations...

Similar Trials